Close Menu


The planned Lighthouse Lab follows a partnership the company announced in June to build a national COVID-19 testing lab in Cardiff.

A number of research groups and companies are exploring use of T-cell response testing in areas like vaccine development and assessing spread of the virus.

A number of diagnostic labs have considered saliva-based SARS-CoV-2 testing but decided against it, while other groups continue to pursue it.

The firm's Diagnostics segment revenues shot up 46 percent while its Discovery & Analytical Solutions segment revenues retreated 10 percent.

News items for in vitro diagnostics industry for the week of July 20, 2020.

The finger prick sample collection device allows the test to be used in a decentralized setting as well as in a high-throughput lab, the company said.

News items for the in vitro diagnostics industry for the week of July 13, 2020.

News items for the in vitro diagnostics industry for the week of July 6, 2020

High-throughput sample prep is becoming critical to COVID-19 testing scale-up, but some labs are experiencing shortages at this stage in the testing workflow.

The company will donate full laboratory set-ups to the effort and provide training and education to implement screening programs.